HPLC vs Mass Spectrometry: How Research Peptide Purity Is Actually Measured

Two instruments generate most of the numbers on a research peptide COA. One is a high performance liquid chromatograph. The other is a mass spectrometer. They answer different questions, and a fair amount of confusion in this market comes from treating them as interchangeable. They are not. HPLC tells you how clean a sample is. Mass spectrometry tells you what the main component is. A defensible quality claim needs both, and knowing which instrument produced which number is the difference between reading a COA and merely looking at one.

HPLC: separating the sample into parts

HPLC, high performance liquid chromatography, is a separation technique. The sample is dissolved and pumped at high pressure through a column packed with fine particles. For peptides, the standard configuration is reversed-phase HPLC on a C18 column: the particle surfaces are coated with 18-carbon hydrocarbon chains, and components separate based on how strongly they interact with that hydrophobic surface.

The run uses a gradient. The mobile phase starts mostly aqueous and becomes progressively more organic, typically water and acetonitrile with a small amount of trifluoroacetic acid. Weakly retained components elute early. Strongly retained ones elute late. Each component leaves the column at a characteristic retention time and passes through a UV detector, usually set near 214 nm, where the peptide backbone absorbs.

The output is a chromatogram: detector signal plotted against time. A clean sample shows one dominant peak and a quiet baseline. A messy sample shows a main peak surrounded by smaller ones, which for synthetic peptides are usually deletion sequences, truncated chains, oxidized variants, or other closely related byproducts of synthesis.

Purity comes from integration. Software measures the area under every peak, and hplc peptide purity is reported as the main peak's area divided by the total area of all peaks, expressed as a percentage. A COA line reading 99.2% by RP-HPLC means the main peak accounted for 99.2% of the detected peak area under that method. What that figure includes and excludes is a topic of its own, and we cover it in detail in our article on what 99% purity actually means.

What HPLC cannot tell you

Here is the limitation that matters. The UV detector registers absorbance, not identity. It reports that something eluted at 12.4 minutes. It does not report what that something was. Retention time is consistent for a given compound under a given method, but it is not a fingerprint. Two different peptides can co-elute. A wrong sequence with the right hydrophobicity can produce a beautiful single peak.

So a chromatogram alone supports a narrow statement: the sample is dominated by one component under these separation conditions. It does not support the statement that the component is the peptide on the label. Skepticism here is not paranoia. It is just reading the instrument's output for what it is.

HPLC also misses anything the method does not detect. Water bound in the lyophilized powder, residual salts, and counterions such as TFA do not show up as peaks in a standard peptide chromatogram. The purity percentage is silent about all of them.

Mass spectrometry: weighing the molecule

A mass spectrometer ionizes the sample and measures the mass-to-charge ratio of the resulting ions. For peptides, two ionization techniques dominate. Electrospray ionization, ESI, sprays the dissolved sample through a charged capillary and tends to produce multiply charged ions, which software deconvolutes into a molecular mass. MALDI-TOF embeds the sample in a UV-absorbing matrix, fires a laser at it, and clocks the flight time of the ions down a tube, with heavier ions arriving later.

Either way, the deliverable is a measured molecular mass. That number is compared against the theoretical mass calculated from the target amino acid sequence. Every sequence has an exact expected mass. A peptide with a theoretical monoisotopic mass of 1619.86 Da should produce an observed mass within the instrument's tolerance of that value, typically a fraction of a dalton on a well-calibrated system. Agreement between observed and theoretical mass is the core evidence that the main component is the intended molecule.

Mass spectrometry earns its keep on failure modes that HPLC handles poorly. A deletion sequence missing one glycine differs from the target by 57 Da, trivial to spot by mass, sometimes nearly invisible by retention time. Oxidation adds 16 Da. An incompletely removed protecting group adds its own defined mass. Each error in synthesis leaves a specific arithmetic signature, and the spectrum shows it.

What mass spec cannot tell you

Mass spectrometry has blind spots of its own, and they are the mirror image of HPLC's.

• It is a poor purity meter. Different molecules ionize with different efficiency, so peak heights in a spectrum do not translate into percentages of the sample. A minor impurity that ionizes well can look large. A significant impurity that ionizes badly can vanish. Purity numbers belong to the chromatograph.
• Mass is not sequence. Two peptides with the same amino acids in different order have identical masses. Standard MS confirms composition, not arrangement. Distinguishing sequence isomers requires tandem MS/MS fragmentation, which routine COA testing rarely includes.
• It says nothing about quantity. A spectrum confirms what is present, not how much material is in the vial.

Purity and identity are different questions

This is the sentence to retain from this article. Purity asks: how much of the detected material is one component? Identity asks: is that component the molecule on the label? HPLC answers the first. Mass spectrometry answers the second. Neither answers both.

Run the failure cases. A sample can be 99.5% pure by HPLC and be the wrong peptide entirely, one clean peak of the wrong molecule. A sample can pass an identity check by mass spec while being 80% junk, right molecule, filthy vial. Only the pair of measurements together supports the claim a researcher actually cares about: this vial contains substantially one component, and that component is the stated sequence.

So when you evaluate a COA, look for both instruments. A purity percentage sourced to RP-HPLC with the method described. An observed mass sourced to ESI-MS or MALDI-TOF, printed next to the theoretical mass so you can compare the two yourself. If a document shows only one of the two, you have half an answer. If it shows a purity percentage attributed to mass spec, you have a document written by someone who does not understand their own instruments, which is its own kind of answer.

How this applies at NEPC

Our standard is mechanical, not aspirational. Every lot in our research peptide catalog is tested by an independent third party lab, and no lot is sold below 99.0% chromatographic purity. The supporting documents live in our Certificate of Analysis Library, matched to lot numbers, so the chromatograms and mass data described above are things you can inspect rather than accept. The scope of what we guarantee is written into our terms.

Do not trust a summary line, ours included. Open the report. Find the retention time, the integration, the observed mass, the theoretical mass. The instruments are honest. The question is whether the paperwork lets you hear them.

All products discussed are for in-vitro laboratory research use only and are not for human or animal use. Nothing here is medical, legal, or purchasing advice.